Effects of statins on serum sCD40, sCD146 and PAPP-An in patients with coronary heart disease
serum sCD40, sCD146 and PAPP-An in patients with coronary heart disease
Ključne reči:
0
Sažetak
0
Reference
Alonso, R., Perez de Isla, L., Muñiz-Grijalvo, O., Diaz-Diaz, J.L. and Mata, P., 2018. Familial hypercholesterolaemia diagnosis and management. Eur. Cardiol., 13: 14-20. https://doi.org/10.15420/ecr.2018:10:2
Caterina, R.D., Radico, F. and Marzilli M., 2020. What dictates prognosis in myocardial ischemic syndromes: myocardial ischemia or coronary atherosclerosis? Heart Metab., 81: 23-26. https://doi.org/10.31887/hm.2020.81/rdecaterina
Chen, L., Chen, X.W., Huang, X., Song, B.L., Wang, Y. and Wang, Y., 2019. Regulation of glucose and lipid metabolism in health and disease. Sci. China. Life Sci., 62: 1420-1458. https://doi.org/10.1007/s11427-019-1563-3
Chinetti, G., Fruchart, J.C. and Staels, B., 2003. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function. Curr. Opin. Lipidol., 14: 459-68. https://doi.org/10.1097/00041433-200310000-00006
Danesh, J., 2022. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ, 321: 199-204. https://doi.org/10.1136/bmj.321.7255.199
de Pádua Borges, R., Degobi, N.A.H. and Bertoluci, M.C., 2021. Choosing statins: A review to guide clinical practice. Arch. Endocrinol. Metab., 64: 639-653. https://doi.org/10.20945/2359-3997000000306
Diamantis, E., Kyriakos, G., Quiles-Sanchez, L.V., Farmaki, P. and Troupis, T., 2017. The anti-inflammatory effects of statins on coronary artery disease: An updated review of the literature. Curr. Cardiol. Rev., 13: 209-216. https://doi.org/10.2174/1573403X13666170426104611
Hu, Z.C., Wu, L.M., Liu, S.Y., Shen, L.S., Zhao, M.H., Liu, L.M., Ding, L.G. Zheng, L.H. and Yao, Y., 2019. Clinical characteristics of cardiomyopathies complicated with ventricular thrombosis. Zhonghua Yi Xue Za Zhi, 99: 3587-3591. https://doi.org/10.3760/cma.j.issn.0376-2491.2019.45.011
Huang, S.H., Wu, C.H., Jiang, S., Bahner, I., Lossinsky, A.S. and Jong, A.Y., 2011. HIV-1 gp41 ectodomain enhances cryptococcus neoformans binding to human brain microvascular endothelial cells via gp41 core-induced membrane activities. Biochem. J., 438: 457-66. https://doi.org/10.1042/BJ20110218
Jia, G. and Sowers, J.R., 2021. Hypertension in diabetes: An update of basic mechanisms and clinical disease. Hypertension, 78: 1197-1205. https://doi.org/10.1161/HYPERTENSIONAHA.121.17981
Lopau, K. and Wanner, C., 2021. Treatment rationale for coronary heart disease in advanced CKD. Herz., 46: 221-227. https://doi.org/10.1007/s00059-021-05025-2
Parikh, R.R., Folsom, A.R., Misialek, J.R., Rosamond, W.D., Chang, P.P., Tang W.H. and Cushman, M., 2019. Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure. Thrombo. Res., 182: 89-94. https://doi.org/10.1016/j.thromres.2019.08.009
Sayols-Baixeras, S., Lluís-Ganella, C., Lucas, G. and Elosua, R., 2014. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl. Clin. Genet., 7: 15-32. https://doi.org/10.2147/TACG.S35301
Shami, A., Edsfeldt, A., Bengtsson, E., Nilsson, J., Shore, A.C., Natali, A., Khan, F., Lutgens, E. and Gonçalves, I., 2021. Soluble CD40 levels in plasma are associated with cardiovascular disease and in carotid plaques with a vulnerable phenotype. J. Stroke., 23: 367-376. https://doi.org/10.5853/jos.2021.00178
Wijkman, M.O., Claggett, B., Vaduganathan, M., Cunningham, J.W., Rørth, R., Jackson, A., Packer, M., Zile, M., Rouleau, J., Swedberg, K., Lefkowitz, M., Shah, S.J., Pfeffer, M.A., McMurray, J.J.V. and Solomon, S.D., 2022. Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: The PARAGON-HF and PARADIGM-HF trials. Cardiovasc. Diabetol., 21: 110. https://doi.org/10.1186/s12933-022-01545-1
Xue, X., Liu, Y, Yang, M., Wang, S., Huang, M., Gao, S., Xu, Y., Gao, S., Li, L. and Yu, C., 2020. Effect of hypercholesterolemia alone or combined with hypertension on the degree of coronary artery stenosis in patients with coronary heart disease angina pectoris: A medical records based retrospective study protocol. Med. (Baltimore), 99: e22225. https://doi.org/10.1097/MD.0000000000022225
Yang, S.W., Zhou, Y.J., Zhao, Y.X., Liu, Y.Y., Tian, X.F., Wang, Z.J., Jia, D.A., Han, H.Y., Hu, B., Shen, H., Gao, F., Wang, L.Y., Lin, J., Pan, G.Z., Zhang, J., Guo, Z.F., Du, J. and Hu, A.Y., 2017. The serum anion gap is associated with disease severity and all-cause mortality in coronary artery disease. J. Geriatr. Cardiol., 14: 392-400. https://doi.org/10.11909/j.issn.1671-5411.2017.06.008
Zhang, X., Kang, J., Zhang, J., Chen, Y., Dai, H., Hu, M., Liu, Y. and Shang, H., 2023. Effectiveness of Yiqi Fumai lyophilized injection for acute heart failure: Rationale and design of the AUGUST-AHF cohort study. Front. Cardiovasc. Med., 9: 1074406. https://doi.org/10.3389/fcvm.2022.1074406
Caterina, R.D., Radico, F. and Marzilli M., 2020. What dictates prognosis in myocardial ischemic syndromes: myocardial ischemia or coronary atherosclerosis? Heart Metab., 81: 23-26. https://doi.org/10.31887/hm.2020.81/rdecaterina
Chen, L., Chen, X.W., Huang, X., Song, B.L., Wang, Y. and Wang, Y., 2019. Regulation of glucose and lipid metabolism in health and disease. Sci. China. Life Sci., 62: 1420-1458. https://doi.org/10.1007/s11427-019-1563-3
Chinetti, G., Fruchart, J.C. and Staels, B., 2003. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function. Curr. Opin. Lipidol., 14: 459-68. https://doi.org/10.1097/00041433-200310000-00006
Danesh, J., 2022. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ, 321: 199-204. https://doi.org/10.1136/bmj.321.7255.199
de Pádua Borges, R., Degobi, N.A.H. and Bertoluci, M.C., 2021. Choosing statins: A review to guide clinical practice. Arch. Endocrinol. Metab., 64: 639-653. https://doi.org/10.20945/2359-3997000000306
Diamantis, E., Kyriakos, G., Quiles-Sanchez, L.V., Farmaki, P. and Troupis, T., 2017. The anti-inflammatory effects of statins on coronary artery disease: An updated review of the literature. Curr. Cardiol. Rev., 13: 209-216. https://doi.org/10.2174/1573403X13666170426104611
Hu, Z.C., Wu, L.M., Liu, S.Y., Shen, L.S., Zhao, M.H., Liu, L.M., Ding, L.G. Zheng, L.H. and Yao, Y., 2019. Clinical characteristics of cardiomyopathies complicated with ventricular thrombosis. Zhonghua Yi Xue Za Zhi, 99: 3587-3591. https://doi.org/10.3760/cma.j.issn.0376-2491.2019.45.011
Huang, S.H., Wu, C.H., Jiang, S., Bahner, I., Lossinsky, A.S. and Jong, A.Y., 2011. HIV-1 gp41 ectodomain enhances cryptococcus neoformans binding to human brain microvascular endothelial cells via gp41 core-induced membrane activities. Biochem. J., 438: 457-66. https://doi.org/10.1042/BJ20110218
Jia, G. and Sowers, J.R., 2021. Hypertension in diabetes: An update of basic mechanisms and clinical disease. Hypertension, 78: 1197-1205. https://doi.org/10.1161/HYPERTENSIONAHA.121.17981
Lopau, K. and Wanner, C., 2021. Treatment rationale for coronary heart disease in advanced CKD. Herz., 46: 221-227. https://doi.org/10.1007/s00059-021-05025-2
Parikh, R.R., Folsom, A.R., Misialek, J.R., Rosamond, W.D., Chang, P.P., Tang W.H. and Cushman, M., 2019. Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure. Thrombo. Res., 182: 89-94. https://doi.org/10.1016/j.thromres.2019.08.009
Sayols-Baixeras, S., Lluís-Ganella, C., Lucas, G. and Elosua, R., 2014. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl. Clin. Genet., 7: 15-32. https://doi.org/10.2147/TACG.S35301
Shami, A., Edsfeldt, A., Bengtsson, E., Nilsson, J., Shore, A.C., Natali, A., Khan, F., Lutgens, E. and Gonçalves, I., 2021. Soluble CD40 levels in plasma are associated with cardiovascular disease and in carotid plaques with a vulnerable phenotype. J. Stroke., 23: 367-376. https://doi.org/10.5853/jos.2021.00178
Wijkman, M.O., Claggett, B., Vaduganathan, M., Cunningham, J.W., Rørth, R., Jackson, A., Packer, M., Zile, M., Rouleau, J., Swedberg, K., Lefkowitz, M., Shah, S.J., Pfeffer, M.A., McMurray, J.J.V. and Solomon, S.D., 2022. Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: The PARAGON-HF and PARADIGM-HF trials. Cardiovasc. Diabetol., 21: 110. https://doi.org/10.1186/s12933-022-01545-1
Xue, X., Liu, Y, Yang, M., Wang, S., Huang, M., Gao, S., Xu, Y., Gao, S., Li, L. and Yu, C., 2020. Effect of hypercholesterolemia alone or combined with hypertension on the degree of coronary artery stenosis in patients with coronary heart disease angina pectoris: A medical records based retrospective study protocol. Med. (Baltimore), 99: e22225. https://doi.org/10.1097/MD.0000000000022225
Yang, S.W., Zhou, Y.J., Zhao, Y.X., Liu, Y.Y., Tian, X.F., Wang, Z.J., Jia, D.A., Han, H.Y., Hu, B., Shen, H., Gao, F., Wang, L.Y., Lin, J., Pan, G.Z., Zhang, J., Guo, Z.F., Du, J. and Hu, A.Y., 2017. The serum anion gap is associated with disease severity and all-cause mortality in coronary artery disease. J. Geriatr. Cardiol., 14: 392-400. https://doi.org/10.11909/j.issn.1671-5411.2017.06.008
Zhang, X., Kang, J., Zhang, J., Chen, Y., Dai, H., Hu, M., Liu, Y. and Shang, H., 2023. Effectiveness of Yiqi Fumai lyophilized injection for acute heart failure: Rationale and design of the AUGUST-AHF cohort study. Front. Cardiovasc. Med., 9: 1074406. https://doi.org/10.3389/fcvm.2022.1074406
Objavljeno
2025/03/20
Broj časopisa
Rubrika
Original paper
Sva prava zadržana (c) 2025 Jing Zhang
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.